Agnieszka Żyłka

Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients

Agnieszka Żyłka, Paulina Dumnicka, Beata Kuśnierz‐Cabala et al. · Mediators of Inflammation · 2018 · 97 citations · Full text

Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes

Agnieszka Żyłka, Agnieszka Gala‐Błądzińska, Paulina Dumnicka et al. · Disease Markers · 2016 · 19 citations · Full text

Summary of meta-analyses of studies involving TIRADS classifications (EU-TIRADS, ACR-TIRADS, and K-TIRADS) in evaluating the malignant potential of focal lesions of the thyroid gland

Katarzyna Dobruch‐Sobczak, Zbigniew Adamczewski, Marek Dedecjus et al. · Journal of Ultrasonography · 2022 · 16 citations · Full text

Low-dose etomidate for the management of severe hypercortisolaemia in different clinical scenarios: a case series and review of the literature

Agnieszka Łebek-Szatańska, Karolina M. Nowak, Wojciech Zgliczyński et al. · Therapeutic Advances in Endocrinology and Metabolism · 2019 · 15 citations · Full text

Role of new biomarkers for the diagnosis of nephropathy associated with diabetes type 2.

Agnieszka Żyłka, Agnieszka Gala‐Błądzińska, Katarzyna Rybak et al. · PubMed · 2015 · 11 citations